Return to homepagePandemic Pact

Covid-19: SARS-CoV-2 genomic surveillance

  • Funded by State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)
  • Total publications:0 publications

Grant number: 142005709

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2023
    2024

  • Known Financial Commitments (USD)

    $1,934,567.53

  • Funder

    State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)

  • Principal Investigator

    Abteilung Übertragbare Krankheiten Sekretariat der

  • Research Location

    N/A

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The subsidy from this contract enables the continuation of the national genomic surveillance program for the SARS-CoV-2 virus. Genomic surveillance focuses on virus variants that cause severe disease and lead to hospitalization, as well as virus variants that could impact clinical care or the effectiveness of vaccination, and samples from the Sentinella reporting system. The surveillance program includes a network of laboratories coordinated by CRIVE. The subsidy covers the coordination of the surveillance program, the sequencing of the viral genome, and the analysis and publication of the data obtained.